Page last updated: 2024-09-02

1,4,7-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane and Pancreatic Neoplasms

1,4,7-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane has been researched along with Pancreatic Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aruva, MR; Cardi, CA; Chakrabarti, A; Opitz, AW; Thakur, ML; Wagner, NJ; Wickstrom, E; Zhang, K1

Other Studies

1 other study(ies) available for 1,4,7-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane and Pancreatic Neoplasms

ArticleYear
Radiohybridization PET imaging of KRAS G12D mRNA expression in human pancreas cancer xenografts with [(64)Cu]DO3A-peptide nucleic acid-peptide nanoparticles.
    Cancer biology & therapy, 2007, Volume: 6, Issue:6

    Topics: Animals; Copper Radioisotopes; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 1-Ring; Humans; Mice; Nanoparticles; Neoplasm Transplantation; Pancreatic Neoplasms; Peptide Nucleic Acids; Peptides; Positron-Emission Tomography; Proto-Oncogene Proteins p21(ras); RNA, Messenger

2007